Botulinum Neurotoxin: Advances in Diagnostics and Healthcare Applications

Authors

  • Sandeep Kumar Vashist HSG-IMIT-Institut für Mikro-und Informationstechnik, Georges-Koehler-Allee 103, 79110 Freiburg, Germany
  • Gregory B. Stevens Albert-Ludwigs-Universität Freiburg, Stefan-Meier-Str. 21, 79104 Freiburg, Germany
  • Thomas van Oordt HSG-IMIT-Institut für Mikro-und Informationstechnik, Georges-Koehler-Allee 103, 79110 Freiburg, Germany

DOI:

https://doi.org/10.6000/1927-5129.2013.09.72

Abstract

Editorial

References

Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: A clinical and epidemiological review. Ann Intern Med 1998; 129: 221-8. http://dx.doi.org/10.7326/0003-4819-129-3-199808010-00011

Gaya JG, Agni R, Miller JE. Clostridium botulinum and the clinical laboratorian. Arch Pathol Lab Med 2004; 128: 653-62.

Bigalke H, Rummel A. Medical aspects of toxic weapons. Toxicology 2005; 214: 210-20. http://dx.doi.org/10.1016/j.tox.2005.06.015

European Centre for Disease Prevention and Control. Annual Epidemiological Report 2012, ESDC 2013.

Juliao PC, Maslanka S, Dykes J, et al. National outbreak of type A foodborne botulism associated with a widely distributed commercially canned hot dog chili sauce. Clin Infect Dis 2013; 56: 376-82. http://dx.doi.org/10.1093/cid/cis901

http://www.companiesandmarkets.com/News/Healthcare-and-Medical/The-global-botox-market-forecast-to-reach-2-9-billion-by-2018/NI2991 (Accessed on 04.10.2013)

http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformation

forPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/

UCM143989.pdf (Accessed on 04.10.2013)

http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDeveloped

andApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm080509.htm

(Accessed on 02.10.2013)

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm175013.htm (Accessed on 04.10.2013)

Cai S, Singh BR, Sharma S. Botulism diagnostics: from clinical symptoms to in vitro assays. Critical Reviews in Microbiology 2007; 33: 109-25. http://dx.doi.org/10.1080/10408410701364562

Lindstrom M, Korkeala H. Laboratory diagnostics of botulism. Clinical Microbiol Rev 2006; 19: 298-14. http://dx.doi.org/10.1128/CMR.19.2.298-314.2006

Satterfield BA, Stewart AF, Lew CS, Pickett DO, Cohen MN, Moore EA, et al. A quadruplex real-time PCR assay for rapid detection and differnetiation of the Clostridium botulinum toxin genes A, B, E and F. J Med Microbiol 2010; 59: 55-64. http://dx.doi.org/10.1099/jmm.0.012567-0

Ligler FS, Taitt CR, Shriver-Lake LC, Sapsford KE, Shubin Y, Golden JP. Array biosensor for detection of toxins. Anal Bioanal Chem 2003; 377: 469-77. http://dx.doi.org/10.1007/s00216-003-1992-0

Stevens GB, Silver DA, Zgaga-Griesz A, et al. Bioluminescence assay for the highly sensitive detection of botulinum neurotoxin A activity. Analyst 2013; 138: 6154-62. http://dx.doi.org/10.1039/c3an00525a

van Oordt T, Stevens G, Vashist SK, Zengerle R, von Stetten F. Rapid and highly sensitive luciferase reporter assay for the automated detection of botulinum toxin in the centrifugal microfluidic LabDisk platform. RSC Adv 2013. http://dx.doi.org/10.1039/c3ra44482a

Downloads

Published

2021-10-21

How to Cite

Sandeep Kumar Vashist, Gregory B. Stevens, & Thomas van Oordt. (2021). Botulinum Neurotoxin: Advances in Diagnostics and Healthcare Applications. Journal of Basic & Applied Sciences, 9, 562–565. https://doi.org/10.6000/1927-5129.2013.09.72

Issue

Section

Biochemistry